Early events of metastatic dissemination are thought to be initiated by epithelial-to-mesenchymal transition (EMT) in carcinoma cells, promoting tumor cell migration and invasion [1] [2] [3] . Although the involvement of EMT in cancer progression is widely recognized, the potential role of the reverse process, mesenchymal-to-epithelial transition (MET), is less clear. Histological analysis has revealed morphological similarities of primary tumors and metastatic lesions 4 , and it has been reported that E-cadherin levels are elevated in lymph node metastases relative to matched primary tumor samples, both suggesting that EMT in primary tumors may be followed by MET at distant sites 5, 6 . Despite these correlative clinical findings, rigorous functional studies linking MET with metastatic colonization ability are scarce.
Early events of metastatic dissemination are thought to be initiated by epithelial-to-mesenchymal transition (EMT) in carcinoma cells, promoting tumor cell migration and invasion [1] [2] [3] . Although the involvement of EMT in cancer progression is widely recognized, the potential role of the reverse process, mesenchymal-to-epithelial transition (MET), is less clear. Histological analysis has revealed morphological similarities of primary tumors and metastatic lesions 4 , and it has been reported that E-cadherin levels are elevated in lymph node metastases relative to matched primary tumor samples, both suggesting that EMT in primary tumors may be followed by MET at distant sites 5, 6 . Despite these correlative clinical findings, rigorous functional studies linking MET with metastatic colonization ability are scarce.
miRNAs have been recognized as key regulators of normal and pathological processes in metazoan organisms [7] [8] [9] . Several miRNAs have also been shown recently to serve as promoters [10] [11] [12] [13] [14] [15] or suppressors 16, 17 of metastasis, particularly in the early step of tumor invasion. However, relatively little is known about the role of miRNAs in the late step, metastatic colonization of distant organs. The miR-200 family of miRNAs is involved in neurogenesis 18 , regulation of embryonic and adult stem cells and cancer stem cells [19] [20] [21] [22] , chemosensitivity and apoptosis 23, 24 . Notably, miR-200s have recently been shown to inhibit EMT and promote MET by direct targeting of E-cadherin transcriptional repressors Zeb1 and Zeb2 (refs. 25-28) . The observation that the miR-200 family enforces the epithelial phenotype and inhibits EMT and invasion in vitro suggests that these miRNAs are likely to suppress metastasis. However, functional studies have yielded conflicting results in different models of metastasis [29] [30] [31] , casting doubt on the potential therapeutic utility of miR-200s. Furthermore, it remains unclear whether the metastasis-related functions of the miR-200s are mediated entirely or only partially through the Zeb-E-cadherin axis.
Here we show that miR-200s promote metastatic colonization of breast cancer not only by influencing cell-intrinsic epithelial traits through targeting of the Zeb-E-cadherin axis, but also by altering tumor cell-derived secretome through targeting of the Sec23 homolog A (Sec23a)-mediated secretion of metastasis-suppressive proteins, including insulin-like growth factor binding protein 4 (Igfbp4) and tubulointerstitial nephritis antigen-like 1 (Tinagl1). These findings provide new insights into the molecular functions of miR-200s as well as the role of MET and the tumor secretome in metastasis.
RESULTS

Correlation of miR-200 expression with metastatic colonization
To investigate the clinical relevance of miR-200 expression (cluster 1: miR-200b, miR-200a and miR-429; cluster 2: miR-200c and miR-141; Supplementary Fig. 1a ), we performed a retrospective analysis on a series of breast tumor samples (n = 210, Oxford collection) 32 . A composite miR-200 family expression score calculated in each sample as either the median ( Fig. 1a ; P = 0.034) or the mean (P = 0.030) a r t i c l e s 1 1 0 2 VOLUME 17 | NUMBER 9 | SEPTEMBER 2011 nature medicine expression was significantly associated with poor distant relapse-free survival (DRFS) 33 . In particular, miR-429 and miR-200a showed the most significant association with DRFS ( Fig. 1a ; P = 0.001 for miR-429 and P = 0.050 for miR-200a). The miR-200 family expression was associated with estrogen receptor (ER)-positive status (P = 0.019, median expression) and correlated with poor DRFS only in the ER-positive tumors (P = 0.028, n = 122) and not in ER-negative tumors (P = 0.48, n = 77). Furthermore, profiling of miR-200 levels in ten human primary and lung-pleural metastasis samples, including six matched pairs (which we denote as the Meldola collection), revealed higher expression in metastases, reinforcing the potential role of miR200s in metastatic colonization (Fig. 1b) . These findings are consistent with a clinical correlation observed in individuals with serous ovarian carcinoma 34 and an earlier observation in xenograft studies 31 .
To further investigate the importance of miR-200s in metastasis, we profiled miR-200 expression levels in three cancer cell line series that model the progression of breast and bladder cancers. The 4T1 series, including 67NR, 168FARN, 4TO7 and 4T1, are near-isogenic mouse mammary tumor cell lines. Of these lines, only 4T1 cells are capable of spontaneously metastasizing and colonizing distant organs after orthotopic implantation 35, 36 . We found that miR-200s showed greatest expression in the highly metastatic 4T1 cells ( Fig. 1c and Supplementary Fig. 1b) , which was consistent with acquisition of epithelial traits ( Fig. 1d and Supplementary Fig. 2a,b) in 4T1 compared to the weakly metastatic 4TO7 cells 37 . Similarly, elevated expression of miR-200s was also correlated with epithelial traits and greater metastatic ability for the MCF10A human breast cancer 38 ( Fig. 1e and Supplementary Fig. 1b ) and the TSU bladder carcinoma 39 progression series ( Supplementary Fig. 2c -e, Supplementary Table 1 and Supplementary Results). These observations collectively point to the possibility that MET induced by the miR-200 family may be crucial for successful completion of metastasis, particularly in the colonization step.
As E-cadherin is a key mediator of MET, we investigated the clinical relevance of E-cadherin expression in the Oxford cohort. As expected, miR-200 expression was positively correlated with E-cadherin expression (P < 0.001, Spearman correlation) and inversely correlated with Vimentin expression (P < 0.001, Spearman correlation). However, in contrast to the clinical associations observed for miR-200s, E-cadherin expression alone did not have any prognostic power (Fig. 1f) , suggesting that the influence of miR-200s on breast cancer metastasis goes beyond the regulation of E-cadherin and the epithelial phenotype and probably involves genetic targets yet to be described.
miR-200 overexpression enhances lung colonization
To directly test the functional role of miR-200s in metastasis, we stably overexpressed cluster 1 (C1 line), cluster 2 (C2 line) and clusters 1 and 2 simultaneously (C1+C2 line) in the mesenchymal-like, weakly metastatic 4TO7 cells (Supplementary Fig. 3a) . We also generated E-cadherin (CDH1)-overexpressing 4TO7 cells (CDH1 line) to test the importance of E-cadherin as a major downstream effector of miR-200s in metastasis. Notably, although ectopic expression of cluster 1 raised the expression of miR-200b, miR-200a and miR-429, cluster 2 elevated expression of all five miRNAs from both clusters (Supplementary Fig. 3a) , possibly owing to a double-negative feedback mechanism involving Zeb factors 25, 40 . As expected, the C1, C2 and C1+C2 lines expressed CDH1 at higher levels and Zeb1 at lower levels (Fig. 2a,b and Supplementary Fig. 3b,c ) and adopted an epithelial-like phenotype (Fig. 2b) . Notably, EMT inducers such as Snail and Twist, and mesenchymal markers such as N-cadherin and vimentin, remained unaffected upon miR-200 expression (Fig. 2a,b) . The CDH1 line also showed elevated expression of E-cadherin but maintained a mesenchymal morphology (Fig. 2a,b) . All the engineered lines had similar growth kinetics in vitro (data not shown) and in vivo (Supplementary Fig. 3d) .
Parental 4TO7 cells, when inoculated orthotopically in the mammary fat pad, spontaneously disseminate to lungs but have a very low efficiency of colonization 35, 36 . C2 (P = 0.035) and C1+C2 (P = 0.01) lines, both of which overexpress all five members of the miR-200 family, formed 10-to 30-fold more lung-derived tumor colonies relative to vector control cells, suggesting that ectopic miR-200 expression can enhance lung-colonization efficiency (Fig. 2c, Supplementary  Fig. 4a,b and Supplementary Methods), consistent with an earlier report 31 . Of note, the C1 line, which expresses elevated levels of E-cadherin similarly to the C2 and C1+C2 lines, was incapable of efficiently colonizing lungs ( Fig. 2c , P = 0.38). This implies that E-cadherin is probably not the only functional downstream effector a r t i c l e s nature medicine VOLUME 17 | NUMBER 9 | SEPTEMBER 2011 1 1 0 3 of miR-200s, and gene targeting mediated by all five members may be necessary to efficiently stimulate metastasis. In support of this, the CDH1 line also did not phenocopy the C2 and C1+C2 lines (P = 0.08), confirming that miR-200-mediated E-cadherin regulation is not sufficient to promote spontaneous metastatic colonization, but rather other genetic pathways must also be involved ( Fig. 2c and Supplementary Fig. 4a,b) .
As metastasis is a multistep process, we aimed to elucidate the influence of miR-200s on early and late steps of metastasis. To determine whether invasion or intravasation is regulated by miR-200s, we analyzed whole-blood samples for circulating tumor cells. In contrast to the results obtained from the lung-colony assays, miR-200 expression reduced tumor cell entry into circulation from primary tumors ( Fig. 2d and Supplementary Fig. 5a ), possibly through inhibition of EMT, migration and invasion, as observed in vitro (Supplementary Fig. 5c ). Similarly, there was also reduced dissemination of CDH1 cells from primary tumors (Supplementary Fig. 5b ). Together, these data suggested that although miR-200 expression can hinder entry of tumor cells into circulation, those that do intravasate may be more capable of colonizing distant organs.
To test this hypothesis, we inoculated cells directly into venous circulation in mice and measured the incidence of pulmonary metastasis. Tail-vein inoculation resulted in greater metastasis burden for all cell lines tested, with C2 (P < 10 −7 ) and C1+C2 (P < 0.01) lines showing the greatest metastasis potential (Fig. 2e-g ). miR-200-overexpressing lines were only partly dependent on Cdh1 for colonization, as stable knockdown of Cdh1 in C1+C2 lines modestly but insignificantly reduced colonization potential (Fig. 2h) . In summary, our results from both clinical and experimental analyses collectively show that miR-200s can promote distant colonization of breast cancer cells. However, the fact that E-cadherin overexpression alone cannot fully recapitulate the metastasis potential of miR-200-overexpressing lines suggests that other genes or signaling pathways are also likely to be simultaneously targeted to enhance colonization efficiency.
miR-200 family induces global changes in gene expression
To identify such functional gene and pathway targets of miR-200s, we performed microarray analysis. Although we observed global changes in gene expression in C2 and C1+C2 lines, substantially less gene expression change was evident in C1 and CDH1 lines (Fig. 3a) . To analyze the extent of the global changes in gene expression observed, we performed an unbiased hierarchical clustering based on a 1,218-gene-set signature that distinctively defines the parental 4TO7 and the highly metastatic 4T1 cell lines. Notably, we found that C2 and C1+C2 lines clustered with the highly metastatic 4T1 cells, whereas the C1 and CDH1 lines remained clustered with the parental 4TO7 cells (Fig. 3a) , mirroring their spontaneous metastasis potentials (Fig. 2c) . Rigorous gene-set enrichment analyses were also performed to (i) confirm the genome-wide shifts in gene expression, (ii) reveal that PicTarderived miR-200 targets were regulated at a global level, (iii) highlight the global repression of the EMT-like genetic program upon miR-200 expression in 4TO7 cells, (iv) show that Cdh1 overexpression alone causes only a modest expression shift, suggesting that E-cadherin is unlikely to be the only functional mediator of miR-200s and (v) reveal that these genetic changes may influence many cellular functions, including epithelial traits and protein transport and secretion (Fig. 3b,c,  Supplementary Fig. 6, Supplementary Table 2 and Supplementary Results). Furthermore, there was a significant negative association between miR-200 family expression and the miR-200-downregulated gene signature in the Oxford cohort of tumor samples (P < 0.001), suggesting that the global changes in gene expression observed in vitro are likely to be pathologically relevant in breast tumors.
Genomic and proteomic identification of miR-200 targets
Recent studies suggest that in mammalian cells, miRNAs regulate most of their direct targets at both mRNA and protein levels 41 . Therefore, we combined microarray and mass spectrometry (MS) analysis to identify nine candidate genes downregulated at both the RNA and protein level in C1+C2 cells compared with controls (Fig. 4a,b (Fig. 4c) and further validated the findings in MDA-MB-231 human breast cancer and TSU-PR1 bladder cancer cell lines, respectively (Fig. 4d) . Furthermore, miR-200b and miR-200c levels were negatively correlated with mean expression of the nine candidate genes in the NCI-60 panel of cell lines (Fig. 4e) , implying conserved targeting. To assess which of these candidate genes are directly targeted by miR-200s, we cloned the 3′ untranslated regions (3′ UTRs) of eight of the nine candidates for standard luciferase assays. We confirmed direct targeting of three candidates, including cofilin 2 (Cfl2), low-density lipoprotein receptor-related protein 1 (Lrp1) and Sec23a (Fig. 4f) . The 3′ UTRs of Cfl2 and Lrp1 each contain one functional miR-200 target sequence, whereas Sec23a contains two evolutionarily conserved miR-200 target sites that function cooperatively to suppress Sec23a expression (Fig. 4f and Supplementary Fig. 7 ).
Sec23a is a miR-200 target that suppresses metastasis
To test which of the three direct targets most probably mediates miR-200 function in metastasis, we stably knocked down each of the genes in 4TO7 cells (Supplementary Fig. 8a-c) . Stable knockdown did not influence morphology (Supplementary Fig. 8a ), cell proliferation or E-cadherin expression (data not shown). Of the three genes, Sec23a knockdown reduced transwell migration (Fig. 5a ) and increased pulmonary colonization (Fig. 5b,c) , phenocopying miR-200 overexpression (Supplementary Fig. 5c and Fig. 2e,f) . In support of the functional data, endogenous Sec23a transcripts were less abundant in highly metastatic 4T1 and MCFCA1a lines than in the weakly metastatic 4TO7 and MCFCA1h lines and were reduced in the 4TO7 line upon miR-200 overexpression (Supplementary Fig. 8d,e) . Furthermore, SEC23A levels were significantly lower in clinical metastases relative to primary tumors (Fig. 5d,e) , consistent with SEC23A's role as a suppressor of metastatic colonization.
Neither knockdown in 4TO7 cells nor overexpression of Sec23a in 4TO7-C1C2 cells significantly (P > 0.05) influenced spontaneous metastasis (Supplementary Fig. 8f-h ). As Sec23a inhibits migration but increases colonization, it is possible that these two effects may balance each other out. Indeed, evaluation of SEC23A expression as a primary tumor prognostic marker in a large public clinical database of breast cancer 42 did not reveal significant associations (P > 0.05). Overall, both clinical data analysis and experimental animal models suggest that Sec23a is involved in suppressing metastasis, specifically at the step of colonization. However, it should be noted that although Sec23a knockdown can enhance metastatic colonization, overexpression of Sec23a alone is not sufficient to significantly (P > 0.05) suppress metastasis ( Supplementary Fig. 8i,j) .
miR-200 overexpression suppresses Sec23a-mediated secretion
Sec23a is an essential component of COPII vesicles and is involved in anterograde transport of proteins from the endoplasmic reticulum to the Golgi apparatus. Although several recent studies have shown that Sec23a is indispensible for the secretion of extracellular matrix components such as collagens and cartilage oligomeric matrix protein (Comp), and in craniofacial and chondrocyte development [43] [44] [45] , little is known of other classes of proteins influenced by Sec23a-mediated secretion and their potential role in metastasis. To clarify this, we performed MS analysis on conditioned medium from two different Sec23a-knockdown 4TO7 lines. There was a global reduction in secretion of proteins (Supplementary Fig. 9a ), including those involved in wounding (P = 6.4 × 10 −6 ), cell adhesion (P = 1.6 × 10 −5 ), extracellular structure organization (P = 3.8 × 10 −3 ) and inflammatory and immune responses (P = 1.0 × 10 −4 and P = 4.0 × 10 −4 , respectively) (Supplementary Table 4) as defined by the Database for Annotation, Visualization and Integrated Discovery (DAVID) Bioinformatics Resources 46 . Reduced secretion led to intracellular accumulation of proteins such as Comp 44 (Supplementary Fig. 9b ), which in turn resulted in modest endoplasmic reticulum distension as assessed by electron microscopic (EM) analysis (Supplementary Fig. 9c ). There were strong correlations in the levels of Sec23-dependent secreted proteins between the two knockdown lines Sec23a-KD2 and Sec23a-KD3 ( Fig. 6a ; R = 0.9, P < 0.0001) and between Sec23a-KD2 and the C1+C2 line ( Fig. 6a; R=0.43 ; R = 0.43, P < 0.001). Similarly to the Sec23a-KD2 cell line, the C1+C2 line also showed modest endoplasmic reticulum distension by EM analysis, suggesting functional disruption of protein transport (Supplementary Fig. 9c ). Together, these data suggest that expression of Sec23a and the secretory pathway are inhibited by miR-200s.
Igfbp4 and Tinagl1 are Sec23a-dependent metastasis suppressors
To evaluate the clinical relevance of the secretome in cancer progression in humans with breast cancer, we used a large public microarray database 42 to analyze the expression of 35 of 38 genes whose products were reduced in secretion in both Sec23a knockdown lines (secretome gene signature; Fig. 6a ). Low expression was significantly correlated with low relapse-fee survival (RFS; Fig. 6b ; P = 0.0236), reinforcing the idea that these genes are metastasis suppressors. In contrast, average expression of eight of nine candidate miR-200 target genes identified through combined genomic and proteomic analysis (Fig. 4a,b ) correlated with high RFS, but the correlation did not reach significance (P = 0.13, data not shown). This highlights the prominent influence of the Sec23a-mediated secretome in metastasis-free survival.
To uncover the central mediators of the secretome that have metastasis-related functions, we functionally tested three of six genes-Axl (Axl receptor tyrosine kinase), Tinagl1 and Igfbp4-from the secretome signature that were significantly (P < 0 .05) associated with RFS (Supplementary Fig. 9d ). Stable knockdown of Tinagl1 and Igfbp4 in 4TO7 cells (Supplementary Fig. 9e ) increased colonization after intravenous injection (Fig. 6c,d) , phenocopying miR-200 overexpression and Sec23a knockdown. Notably, both TINAGL1 and IGFBP4 were also significantly associated with better distant metastasis-free survival in an independent EMC286 clinical data set 47 (Fig. 6e) , again supporting their role in reducing metastasis. Furthermore, IGFBP4 expression showed a significant (P < 0 .05) lung-tropic association ( Supplementary Fig. 9f ) with metastases in the MSK82 clinical data set 48 . Together, our data imply that the secretome is a major downstream mediator of miR-200s in metastasis and reveal that Tinagl1 and Igfbp4 are secreted suppressors of lung metastasis with potential therapeutic applications.
DISCUSSION
In this study, we show that miR-200s promote metastatic colonization through mechanisms that go beyond cell-intrinsic regulation of epithelial traits through the Zeb-E-cadherin axis (Fig. 6f) . miR-200s also influence tumor cell secretome by direct targeting of the Sec23a-mediated transport pathway, which affects cell-extrinsic tumor-stromal interactions. We further identified Tinagl1 and Igfbp4 as key Sec23a-mediated secretory proteins that substantially reduce metastatic colonization. Our findings support dynamic roles for EMT and MET during different stages of metastasis: whereas EMT and low levels of miR-200s promote invasion and intravasation, MET and high miR-200 expression is required for efficient colonization of secondary organs. This is, to our knowledge, the first large-scale breast cancer clinical study showing a clear clinical association of miR-200 family expression with poor DRFS, particularly in ER-positive breast cancers. Furthermore, miR-200 expression was greater in lung metastases than in primary tumors. In support of the clinical associations, a survey across several different isogenic series of cancer cell lines revealed a strong correlation between miR-200 expression and metastatic ability, which was further supported by functional analysis in vivo.
Several recent studies in animal metastasis models have reported conflicting roles of miR-200s in metastatic progression [29] [30] [31] . These contradictory findings may in part be due to the different models applied in these studies: miR-200s may promote metastasis of breast cancer cells 31 and hinder metastasis of lung adenocarcinoma 29 and pancreatic neuroendocrine cells 30 . However, it is more likely that the net effect of miR-200s in metastasis progression of various cancers depends on several variables across different models, such as the difference in the rate-limiting step of the metastatic cascade and the importance of MET in colonization in different models. In the model system we applied, the 4TO7 tumor cells are inherently highly migratory and invasive in vitro and in vivo, and although ectopic miR-200 expression reduces dissemination, it has a net effect of enhancing the rate-limiting colonization step. In contrast, this outcome is less likely in model systems where earlier steps of metastasis, such as early dissemination through acquisition of EMT-like properties, is the rate-limiting process, as may be the case for the model systems showing metastasis-suppressor functions of miR-200s (refs. 29,30) (see Supplementary Discussion for further discussion on the biphasic role of miR-200s).
Here both clinical and functional data revealed that E-cadherin alone is insufficient to recapitulate all miR-200 phenotypes, suggesting that miR-200s probably influence other genes or pathways during metastasis. We used integrated genomic and proteomic analysis to comprehensively examine the impact of miR-200s on gene expression in cancer cells. miR-200 overexpression led to widespread changes in gene expression toward that of the most metastatic cells. In addition to genes and pathways controlling epithelial characteristics, other cellular processes such as protein transport and secretion were also implicated in miR-200-dependent regulation of metastatic ability. Notably, we showed that the expression of Sec23a is directly suppressed by miR-200s through two evolutionarily conserved target sequences in its 3′ UTR (see Supplementary Discussion for a summary of evidence supporting Sec23a as a functional target of miR-200s).
Thus, in addition to the well-established function of miR-200s in regulating intrinsic cellular properties through Zeb1, Zeb2 and E-cadherin, miR-200s may also have the potential to influence the microenvironment via directed targeting of Sec23a-dependent secretome. Through regulation of this pathway, miR-200s may extend their 
